Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
iniuva logo — we. fight. misfolding.

iniuva

we. fight. misfolding.

Founded 2022 Germany Hamburg, Germany 5 employees Biotechnology, Health Care +1

General Information

Company Name iniuva
Founded Year 2022
Location Germany Hamburg, Germany +1
Employees 5
Industries Biotechnology, Health Care, Life Sciences
Social

Get notified when iniuva moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About iniuva

iniuva is a **biotechnology** and **healthcare** startup founded in **2022** with a focus on revolutionizing drug development. Their slogan "we. fight. misfolding." reflects their dedication to addressing protein misfolding, a crucial mechanism in numerous rare diseases. Their team of medical professionals, scientists, and experts is committed to leveraging AI-powered technology to expedite and enhance the process from candidate identification to clinical approval. This approach significantly reduces development times from years to months, while also elevating drug quality and cost-efficiency. Iniuva's innovative platform offers **rare disease solutions** for the pharmaceutical and biotech industries, providing small-molecule therapies from the discovery phase to approval. They cater to clients looking to diversify their portfolios or enter the orphan drug market, offering the flexibility to acquire or license therapeutic breakthroughs post-approval or collaborate at any stage of product development. By integrating AI across the value chain, iniuva sets a new industry standard in model precision, ultimately enabling the rapid delivery of approved therapeutic products to customers and patients. With a strong emphasis on patient-centric drug development, iniuva is poised to make a significant impact in the biotechnology and healthcare sectors.

Taxonomy: Drug Discovery, Rare Disease Therapies, AI-Powered Platform, Pharmaceutical Development, Biotech Collaboration, Orphan Drug Market, Medical Professionals, Scientific Expertise, Protein Misfolding, Small Molecule Therapies

No funding data available for iniuva yet.

Get notified when iniuva raises funding

iniuva Alternatives & Competitors

iniuva vs
Advenchen Laboratories, LLC
Advenchen Laboratories, LLC

Pioneering novel therapies with promising small molecule kinase inhibitors for a brighter future in...

Series Unknown
6 employees
Biotechnology, Health Care
iniuva vs
Gain Therapeutics
Gain Therapeutics United States

Unfolding the next generation of allosteric small molecule therapies to meet patient needs

IPO
26 employees
Biotechnology, Pharmaceutical
iniuva vs
AmyPore
AmyPore France

New target, new paradigm, new strategy that address the root cause of Alzheimer, Parkinson, and othe...

Non Equity Assistance
2 employees
Biotechnology, Health Care

FAQ About iniuva

we. fight. misfolding.
iniuva was founded in 2022.
iniuva is headquartered in Hamburg, Germany.
iniuva operates in the following industries: Biotechnology, Health Care, Life Sciences.
iniuva has approximately 5 employees.
Top alternatives and competitors to iniuva include Advenchen Laboratories, LLC, Gain Therapeutics, AmyPore, Eloxx Pharmaceuticals, Venenum BioDesign, LLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
iniuva and Advenchen Laboratories, LLC are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors iniuva and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy